연구동향 분석

Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs

노금한 강유라 Mahesh Raj Nepal Rajina Shakya 강미정 강원구 이상규 정혜광 정태천 2017년

논문상세정보
    • 저자 노금한 강유라 Mahesh Raj Nepal Rajina Shakya 강미정 강원구 이상규 정혜광 정태천
    • 제어번호 105258613
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 40 No. 12 [ 2017 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 1345-1355 ( 11쪽)
    • 언어 English
    • 출판년도 2017
    • 등재정보 KCI등재
    • 소장기관 부산대학교 중앙도서관 숙명여자대학교 중앙도서관 영남대학교 중앙도서관 영남대학교 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs' 의 참고문헌

  • Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4
    Tang BK Eur J Clin Pharmacol 47 449-451 [1995]
  • Therapeutic drug monitoring of mycophenolic acid
    Shaw LM Clin J Am Soc Nephrol 2 1062-1072 [2007]
  • The role of intestinal microflora in the formation of the methylthio adduct metabolites of paracetamol. Studies in neomycin-pretreated and germ-free mice
    Mikov M Biochem Pharmacol 37 1445-1449 [1988]
  • The role of intestinal flora in metabolism of phenolic sulfate esters
    Kim DH Biochem Pharmacol 35 3507-3510 [1986]
  • The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases
    Tlaskalova-Hogenova H Cell Mol Immunol 8 110-120 [2011]
  • The metabolism of drugs by the gut flora
    Mikov M Eur J Drug Metab Pharmacokinet 19 201-207 [1994]
  • The influence of gut microbiota on drug metabolism and toxicity
    Li H Expert Opin Drug Metab Toxicol 12 31-40 [2016]
  • The gut flora as a forgotten organ
    O’hara AM EMBO Rep 7 688-693 [2006]
  • The germfree animal in nutritional studies
    Wostmann BS Annu Rev Nutr 1 257-279 [1981]
  • The gastrointestinal microbiota as a site for the biotransformation of drugs
    Sousa T Int J Pharm 363 1-25 [2008]
  • The effect of gut microbiota on drug metabolism
    Kang MJ Expert Opin Drug Metab Toxicol 9 1295-1308 [2013]
  • Studies of the microbial metabolism of flavonoids extracted from the leaves of Diospyros kaki by intestinal bacteria
    Sheng-hai Zhang Archives of Pharmacal Research 38 5 614-619 [2015]
  • Roles of UGT, P450, and gut microbiota in the metabolism of epacadostat in humans
    Boer J Drug Metab Dispos 44 1668-1674 [2016]
  • Role of the normal gut microbiota
    Jandhyala SM World J Gastroenterol 21 8787-8803 [2015]
  • Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin
    강미정 Archives of Pharmacal Research 37 3 371-378 [2014]
  • Role of intestinal microflora in xenobiotic-induced toxicity
    Jeong HG Mol Nutr Food Res 57 84-99 [2013]
  • Role of intestinal microflora in the metabolism of vitamin B-6 and 40-deoxypyridoxine examined using germfree guinea pigs and rats
    Coburn SP J Nutr 119 181-188 [1989]
  • Role of intestinal microbiota in baicalin-induced drug interaction and its pharmacokinetics
    Noh K Molecules 21 337- [2016]
  • Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin
    Kim IS Biochem Pharmacol 122 72-79 [2016]
  • Proton pump inhibitors alter the composition of the gut microbiota
    Jackson MA Gut 65 749-756 [2016]
  • Pharmacologic targeting of bacterial beta-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice
    Loguidice A J Pharmacol Exp Ther 341 447-454 [2012]
  • Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
    Neuvonen PJ Clin Pharmacokinet 47 463-474 [2008]
  • Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite
    Nattel S J Cardiovasc Pharmacol 8 771-777 [1986]
  • NSAID enteropathy and bacteria: a complicated relationship
    Syer SD J Gastroenterol 50 387-393 [2015]
  • Molecular insights into microbial beta-glucuronidase inhibition to abrogate CPT-11 toxicity
    Roberts AB Mol Pharmacol 84 208-217 [2013]
  • Metabolism of drugs and other xenobiotics in the gut lumen and wall
    Ilett KF Pharmacol Ther 46 67-93 [1990]
  • Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis
    Mcgill MR Pharm Res 30 2174-2187 [2013]
  • Medical microbiology
    Gorbach SL - [1996]
  • Mass balance, metabolite profile, and in vitro-in vivo comparison of clearance pathways of deleobuvir, a hepatitis C virus polymerase inhibitor
    Chen LZ Antimicrob Agents Chemother 59 25-37 [2015]
  • Lovastatin production by Aspergillus terreus using agro-biomass as substrate in solid state fermentation
    Jahromi MF J Biomed Biotechnol 2012 196264- [2012]
  • Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs
    Okuda H Drug Metab Dispos 25 270-273 [1997]
  • Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
    Adebayo D Postgrad Med J 82 186-191 [2006]
  • Investigation of endogenous metabolic changes in the urine of pseudo germ-free rats using a metabolomic approach
    Lee SH J Chromatogr B 887-888 8-18 [2012]
  • Intestinal microflora and digestive toxicity of irinotecan in mice
    Brandi G Clin Cancer Res 12 1299-1307 [2006]
  • Intestinal microbiota in human health and disease: the impact of probiotics
    Gerritsen J Genes Nutr 6 209-240 [2011]
  • Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil
    Nakayama H Pharmacogenetics 7 35-43 [1997]
  • Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites
    Zamek-Gliszczynski MJ Eur J Pharm Sci 27 447-486 [2006]
  • Inhibitory effect of ciprofloxacin on beta-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide
    Kodawara T Biopharm Drug Dispos 35 275-283 [2014]
  • Human gut microbiota plays a role in the metabolism of drugs
    Jourova L Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160 317-326 [2016]
  • Gut microbiota-mediated drug interactions between lovastatin and antibiotics
    Yoo DH Drug Metab Dispos 42 1508-1513 [2014]
  • Gut microbiota in autoimmunity: potential for clinical applications
    김동현 Archives of Pharmacal Research 39 11 1565-1576 [2016]
  • Gut microbiota and tacrolimus dosing in kidney transplantation
    Lee JR PLoS ONE 10 e0122399- [2015]
  • Gut microbiome interactions with drug metabolism, efficacy, and toxicity
    Wilson ID Transl Res 179 204-222 [2017]
  • Evaluation of pharmacokinetic differences of acetaminophen in pseudo germ-free rats
    Lee SH Biopharm Drug Dispos 33 292-303 [2012]
  • Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson’s disease
    Hashim H PLoS ONE 9 e112330- [2014]
  • Enzyme activities of the hindgut microflora of laboratory animals and man
    Rowland IR Xenobiotica 16 519-523 [1986]
  • Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction
    Yoo HH J Hypertens 34 156-162 [2016]
  • Diversity, stability and resilience of the human gut microbiota
    Lozupone CA Nature 489 220-230 [2012]
  • Developing a metagenomic view of xenobiotic metabolism
    Haiser HJ Pharmacol Res 69 21-31 [2013]
  • Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction
    Ohno S Drug Metab Dispos 37 32-40 [2009]
  • Defining the role of gut bacteria in the metabolism of deleobuvir: in vitro and in vivo studies
    Mccabe M Drug Metab Dispos 43 1612-1618 [2015]
  • Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion
    Shaw LM Ther Drug Monit 23 305-315 [2001]
  • Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes
    Wang M FEMS Microbiol Ecol 54 219-231 [2005]
  • Clinical pharmacokinetics of amlodipine
    Meredith PA Clin Pharmacokinet 22 22-31 [1992]
  • Clinical pharmacokinetics of amiodarone
    Latini R Clin Pharmacokinet 9 136-156 [1984]
  • Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal beta-glucuronidase activity
    Zhong ZY Acta Pharmacol Sin 37 1002-1012 [2016]
  • Chemical transformation of xenobiotics by the human gut microbiota
    Koppel N Science 356 eaag2770- [2017]
  • Change in pharmacokinetics of mycophenolic acid as a function of age in rats and effect of coadministered amoxicillin/clavulanate
    Ishizaki J Biol Pharm Bull 35 1009-1013 [2012]
  • Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse
    Vyas KP Drug Metab Dispos 18 203-211 [1990]
  • Bidirectional interactions between indomethacin and the murine intestinal microbiota
    Liang X Elife 4 e08973- [2015]
  • Bacterial biogeography of the human digestive tract
    Stearns JC Sci Rep 1 170- [2011]
  • Bacterial beta-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
    Saitta KS Xenobiotica 44 28-35 [2014]
  • Antipsychotics and the gut microbiome:olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
    Davey KJ Transl Psychiatry 3 e309- [2013]
  • Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation
    Zhu Y Drug Metab Dispos 42 245-249 [2014]
  • Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917on amidarone absorption in rats
    Matuskova Z PLoS ONE 9 ee87150- [2014]
  • A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes
    Turpeinen M Drug Metab Dispos 37 1017-1024 [2009]